|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating Activities: | |||||
| Net loss | |||||
| Reconciliation of net loss to cash used in operations: | |||||
| Non-cash lease expense | |||||
| Depreciation and amortization | |||||
| Write-down of raw material inventory | |||||
| Debt Issuance Costs | |||||
| Stock compensation expense | |||||
| Impairment of uranium properties | |||||
| Uranium royalties write-off | |||||
| Convertible Notes loss | |||||
| Series A-1 Convertible Notes | |||||
| Series B-1 Convertible Notes | |||||
| Effect of changes in operating working capital items: | |||||
| Increase in inventory | |||||
| (Increase) decrease in other long-term assets | |||||
| Decrease in prepaids and other current assets | |||||
| (Decrease) increase in payables and accrued liabilities | |||||
| Net Cash Used In Operating Activities | |||||
| Investing Activities: | |||||
| Capital expenditures | |||||
| Proceeds from sale of assets | |||||
| Net Cash Used In Investing Activities | |||||
| Financing Activities: | |||||
| Issuance of Common Stock, net of issuance costs | |||||
| Proceeds from Convertible Notes | |||||
| Series A-1 Convertible Notes | |||||
| Series B-1 Convertible Notes | |||||
| Total proceeds from Convertible Notes | |||||
| Proceeds from exercise of stock options | |||||
| Payment of Convertible Notes issuance costs | |||||
| Payment of debt issuance costs | |||||
| Payment of minimum withholding taxes on net share settlements of equity awards | |||||
| Payments on finance lease liabilities | |||||
| Net Cash Provided By Financing Activities | |||||
| Net increase (decrease) in Cash and Cash Equivalents | |||||
| Cash and Cash Equivalents, Beginning of Period | |||||
| Cash and Cash Equivalents, End of Period | |||||
| Supplemental Cash Flow Information | |||||
| Non-cash right-of-use asset obtained in exchange for operating lease liability | |||||
| Non-cash right-of-use asset obtained in exchange for finance lease liability | |||||
| Accrued capital expenditures (at end of period) | |||||
| Common Stock issued for Convertible Notes | |||||
| Series A-1 Convertible Notes | |||||
| Series B-1 Convertible Notes | |||||
| Accrued debt issuance costs (at end of period) | |||||
| Total Supplemental Cash Flow Information | |||||
Loading...